MILWAUKEE, WI – This evening, the Supreme Court of the United States granted the stay requested by the Department of Justice (DOJ) and Danco in Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al. allowing mifepristone’s FDA approval to remain unchanged as the case proceeds through the Fifth Circuit Court of Appeals and the Supreme Court. This means mifepristone will remain accessible and on the market while the Fifth Circuit hears DOJ and Danco’s appeal as well as any appeal to the Supreme Court.
Statement from Michelle Velasquez, legal director for Planned Parenthood of Wisconsin
“We are relieved that access to mifepristone will remain protected while this meritless case proceeds. Mifepristone is safe, effective, and has been used by more than five million people in the United States since the FDA approved it more than 20 years ago. We can take a breath, but we are not losing our vigilance. Anti-abortion politicians and their allies will not stop until abortion is banned nationwide. Patients deserve to access the medication they need and providers should be able to provide that medication without unnecessary interference from the judiciary, or politicians for that matter.
“Planned Parenthood will continue to fight so that everyone can make their own decisions about their bodies, lives, and futures. In the meantime, Planned Parenthood of Wisconsin’s doors are open and is working to provide patients with the sexual and reproductive health services and information they need to determine the course of their own life. For more information go to ppwi.org.”
